000 01294 a2200361 4500
005 20250514211804.0
264 0 _c20050310
008 200503s 0 0 spa d
022 _a1695-4033
024 7 _a10.1016/s1695-4033(04)78449-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFernández González, N
245 0 0 _a[Oral sildenafil: a promising drug for persistent neonatal pulmonary hypertension].
_h[electronic resource]
260 _bAnales de pediatria (Barcelona, Spain : 2003)
_cDec 2004
300 _a567-8 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdministration, Oral
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aMale
650 0 4 _aPersistent Fetal Circulation Syndrome
_xdrug therapy
650 0 4 _aPiperazines
_xtherapeutic use
650 0 4 _aPurines
650 0 4 _aSildenafil Citrate
650 0 4 _aSulfones
650 0 4 _aVasodilator Agents
_xtherapeutic use
700 1 _aRodríguez Fernández, A
700 1 _aJerez Rojas, J
700 1 _aParrondo Garrido, S M
700 1 _aMartínez Mengual, L
773 0 _tAnales de pediatria (Barcelona, Spain : 2003)
_gvol. 61
_gno. 6
_gp. 567-8
856 4 0 _uhttps://doi.org/10.1016/s1695-4033(04)78449-0
_zAvailable from publisher's website
999 _c15259487
_d15259487